125 related articles for article (PubMed ID: 15632911)
21. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
22. Head and neck squamous cell carcinoma and metachronous second primaries.
Haremza C; Baert M; Pascual C; Biet-Hornstein A; Page C
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Oct; 136(5):367-372. PubMed ID: 31208879
[TBL] [Abstract][Full Text] [Related]
23. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival.
Kyrgidis A; Tzellos TG; Kechagias N; Patrikidou A; Xirou P; Kitikidou K; Bourlidou E; Vahtsevanos K; Antoniades K
Eur J Cancer; 2010 Jun; 46(9):1563-72. PubMed ID: 20338745
[TBL] [Abstract][Full Text] [Related]
25. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998.
Barzan L; Talamini R; Franchin G; Vaccher E; Politi D; Minatel E; Gobitti C
Cancer; 2002 Aug; 95(3):540-52. PubMed ID: 12209746
[TBL] [Abstract][Full Text] [Related]
26. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
28. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
29. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
[TBL] [Abstract][Full Text] [Related]
30. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
31. Racial differences in stage and survival in head and neck squamous cell carcinoma.
Nichols AC; Bhattacharyya N
Laryngoscope; 2007 May; 117(5):770-5. PubMed ID: 17473666
[TBL] [Abstract][Full Text] [Related]
32. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
33. An assessment of risk factors for the development of a second primary malignancy in the head and neck.
Bhattacharyya N
Ear Nose Throat J; 2006 Feb; 85(2):121-5. PubMed ID: 16579204
[TBL] [Abstract][Full Text] [Related]
34. In response to Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases (Laryngoscope 2008;118:1350-1356, 2008).
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2009 Jul; 119(7):1447. PubMed ID: 19358206
[No Abstract] [Full Text] [Related]
35. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
36. Staging and survival analysis for nonsquamous cell carcinomas of the larynx.
Lin HW; Bhattacharyya N
Laryngoscope; 2008 Jun; 118(6):1003-13. PubMed ID: 18388773
[TBL] [Abstract][Full Text] [Related]
37. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
39. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck.
Pytynia KB; Grant JR; Etzel CJ; Roberts DB; Wei Q; Sturgis EM
J Clin Oncol; 2004 Oct; 22(19):3981-8. PubMed ID: 15459221
[TBL] [Abstract][Full Text] [Related]
40. Synchronous and metachronous head and neck carcinomas.
Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
